Maximus, Inc. (NYSE:MMS) Shares Sold by Wellington Management Group LLP

Wellington Management Group LLP reduced its stake in Maximus, Inc. (NYSE:MMS) by 19.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 402,880 shares of the health services provider’s stock after selling 97,699 shares during the quarter. Wellington Management Group LLP owned about 0.67% of Maximus worth $37,532,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Quadrature Capital Ltd grew its stake in Maximus by 6.0% during the 3rd quarter. Quadrature Capital Ltd now owns 10,934 shares of the health services provider’s stock valued at $1,018,000 after purchasing an additional 621 shares during the last quarter. Quarry LP increased its stake in shares of Maximus by 48.0% in the third quarter. Quarry LP now owns 1,017 shares of the health services provider’s stock worth $95,000 after acquiring an additional 330 shares during the period. Petrus Trust Company LTA increased its stake in shares of Maximus by 2.7% in the third quarter. Petrus Trust Company LTA now owns 7,084 shares of the health services provider’s stock worth $660,000 after acquiring an additional 185 shares during the period. Holocene Advisors LP raised its holdings in shares of Maximus by 6.5% during the third quarter. Holocene Advisors LP now owns 3,927 shares of the health services provider’s stock worth $366,000 after purchasing an additional 239 shares during the last quarter. Finally, Verition Fund Management LLC lifted its position in Maximus by 83.3% during the third quarter. Verition Fund Management LLC now owns 8,331 shares of the health services provider’s stock valued at $776,000 after purchasing an additional 3,786 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Maximus

In related news, insider Michelle F. Link sold 1,363 shares of Maximus stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total value of $126,159.28. Following the completion of the transaction, the insider now owns 6,567 shares in the company, valued at $607,841.52. The trade was a 17.19 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.40% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Thursday, November 28th.

Maximus Stock Down 0.5 %

Shares of MMS stock opened at $70.67 on Friday. Maximus, Inc. has a twelve month low of $70.00 and a twelve month high of $93.97. The stock has a market cap of $4.26 billion, a P/E ratio of 14.13 and a beta of 0.73. The stock has a 50 day moving average of $83.01 and a 200 day moving average of $86.70. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Stockholders of record on Friday, November 15th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.70%. The ex-dividend date was Friday, November 15th. Maximus’s dividend payout ratio (DPR) is 24.00%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.